Vaxcyte, Inc.
PCVX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001649094
In the last 90 days, Vaxcyte, Inc. insiders filed 0 open-market purchases and 8 sales; 331 institutions reported holding it in 13F filings for Q2 2026, worth $9.71B in total; Maverick Capital is the only superinvestor holding it.
13F holders, Q1 2026
Institutional positions in Vaxcyte, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 336
- +47 vs. Q4 2025
- Shares held
- 162.5M
- +28.4M (+21.2%) vs. Q4 2025
- Total value
- $9.44B
- +$3.25B (+52.5%) vs. Q4 2025
- New holders
- 71
- 129 more added
- Sold out
- 24
- 81 more reduced
6 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PCVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 331 | $9.71B |
| Q1 2026 | 336 | $9.44B |
| Q4 2025 | 295 | $6.81B |
| Q3 2025 | 285 | $5.09B |
| Q2 2025 | 294 | $4.80B |
| Q1 2025 | 315 | $5.88B |
| Q4 2024 | 323 | $11.5B |
| Q3 2024 | 329 | $15.6B |
| Q2 2024 | 265 | $9.26B |
| Q1 2024 | 251 | $8.13B |
| Q4 2023 | 223 | $6.47B |
| Q3 2023 | 202 | $5.17B |
| Q2 2023 | 197 | $5.00B |
| Q1 2023 | 188 | $3.15B |
| Q4 2022 | 198 | $3.91B |
| Q3 2022 | 126 | $1.36B |
| Q2 2022 | 106 | $1.12B |
| Q1 2022 | 88 | $1.20B |
| Q4 2021 | 87 | $1.06B |
| Q3 2021 | 78 | $1.10B |
| Q2 2021 | 75 | $972.7M |
| Q1 2021 | 74 | $869.2M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Vaxcyte, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Fiduciary Trust Co | 842,273 | $48.9M | 0.01% | +842,273 | New |
| Novo Holdings A/S | 860,000 | $50.0M | 4.05% | −56,160−6.1% | Reduced |
| Capital Research Global Investors | 912,688 | $53.0M | 0.01% | +69,710+8.3% | Added |
| Eversept Partners, LP | 924,193 | $53.7M | 3.54% | −273,529−22.8% | Reduced |
| JPMorgan Chase & Co | 1,008,314 | $55.4M | 0.00% | −77,205−7.1% | Reduced |
| Price T Rowe Associates Inc | 976,429 | $56.7M | 0.01% | −198,910−16.9% | Reduced |
| Standard Life Aberdeen plc | 978,969 | $56.9M | 0.09% | −796−0.1% | Reduced |
| Northern Trust Corp | 1,144,469 | $66.5M | 0.01% | +110,289+10.7% | Added |
| Assenagon Asset Management S.A. | 1,164,813 | $67.7M | 0.11% | +620,085+113.8% | Added |
| Bellevue Group AG | 1,190,697 | $69.2M | 1.65% | +1,190,697 | New |
| Bank of America Corp | 1,216,843 | $70.7M | 0.01% | +515,209+73.4% | Added |
| Farallon Capital Management, L.L.C. | 1,261,000 | $73.3M | 0.43% | +1,256,000+25,120.0% | Added |
| Goldman Sachs Group Inc | 1,275,036 | $74.1M | 0.01% | +196,916+18.3% | Added |
| UBS Group AG | 1,337,390 | $77.7M | 0.01% | +243,797+22.3% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,372,425 | $79.8M | 28.51% | 00.0% | Unchanged |
| Eventide Asset Management, LLC | 1,374,292 | $79.8M | 1.32% | +457,177+49.8% | Added |
| Maverick Capital LtdSuperinvestorMaverick Capital | 1,377,738 | $80.1M | 0.93% | +23,501+1.7% | Added |
| Charles Schwab Investment Management Inc | 1,403,948 | $81.6M | 0.01% | +110,118+8.5% | Added |
| Polar Capital Holdings Plc | 1,425,788 | $82.9M | 0.36% | −246,995−14.8% | Reduced |
| Jennison Associates LLC | 1,698,011 | $98.7M | 0.07% | +1,020,458+150.6% | Added |
| Caligan Partners LP | 2,060,719 | $119.7M | 8.47% | +355,904+20.9% | Added |
| D. E. Shaw & Co., Inc. | 2,865,318 | $166.5M | 0.13% | −765,735−21.1% | Reduced |
| Kynam Capital Management, LP | 2,922,335 | $169.8M | 10.78% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 3,201,283 | $186.1M | 0.01% | +334,978+11.7% | Added |
| Westfield Capital Management Co LP | 3,646,138 | $211.9M | 0.89% | +106,421+3.0% | Added |
| Deep Track Capital, LP | 4,300,000 | $249.9M | 5.16% | +300,000+7.5% | Added |
| State Street Corp | 4,440,519 | $258.0M | 0.01% | −539,486−10.8% | Reduced |
| Paradigm Biocapital Advisors LP | 4,793,020 | $278.5M | 5.69% | +725,000+17.8% | Added |
| Wellington Management Group LLP | 5,614,597 | $326.3M | 0.06% | −351,713−5.9% | Reduced |
| Vanguard Capital Management LLC | 6,266,701 | $364.2M | 0.01% | +6,266,701 | New |
| Vanguard Portfolio Management LLC | 6,279,545 | $364.9M | 0.02% | +6,279,545 | New |
| BlackRock, Inc. | 10,971,816 | $637.6M | 0.01% | +725,438+7.1% | Added |
| Ra Capital Management, L.P. | 11,474,599 | $666.8M | 7.07% | +750,000+7.0% | Added |
| T. Rowe Price Investment Management, Inc. | 12,126,017 | $704.6M | 0.49% | +829,684+7.3% | Added |
| FMR LLC | 16,492,861 | $958.4M | 0.05% | +2,658,347+19.2% | Added |
| Janus Henderson Group PLC | 16,575,875 | $960.2M | 0.46% | +3,188,687+23.8% | Added |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −450,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −326,574−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −275,000−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −89,822−100.0% | Sold out |
| Harbor Capital Advisors, Inc. | 0 | $0 | 0.00% | −31,274−100.0% | Sold out |
| Alberta Investment Management Corp | 0 | $0 | 0.00% | −30,100−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −24,485−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −15,731−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −10,513−100.0% | Sold out |
| Perbak Capital Partners LLP | 0 | $0 | 0.00% | −8,899−100.0% | Sold out |
| Mackenzie Financial Corp | 0 | $0 | 0.00% | −7,174−100.0% | Sold out |
| Qsemble Capital Management, LP | 0 | $0 | 0.00% | −6,701−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −5,399−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −5,025−100.0% | Sold out |
| Neo Ivy Capital Management | 0 | $0 | 0.00% | −4,803−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −3,635−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,549−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −831−100.0% | Sold out |
| International Assets Investment Management, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| SageView Advisory Group, LLC | 0 | $0 | 0.00% | −114−100.0% | Sold out |
| Turning Point Benefit Group, Inc. | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Financial Network Wealth Advisors LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Root Financial Partners, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Private Wealth Asset Management, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Norges Bank | – | – | – | – | Not filed |
| CIBC Private Wealth Group, LLC | – | – | – | – | Not filed |
| CIBC World Markets Corp | – | – | – | – | Not filed |
| Comerica Bank | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |